Fanhua Inc. (NASDAQ: FANH) — FY2019 Form 20-F summary
Entity and period note: The request identifies AIFU Inc. and 2019 Q4, but the supplied filing is Fanhua Inc.’s annual report for the fiscal year ended December 31, 2019. It reports full-year, not standalone fourth-quarter, results. Figures below are for Fanhua; the filing provides no clear basis to associate it with AIFU.
Business context and reporting period
Fanhua is a China-focused insurance intermediary providing insurance agency and claims-adjusting services. It distributes life, health, and property-and-casualty (P&C) products through agents and online platforms. The filing reports under U.S. GAAP; financial figures are primarily in RMB. Unless stated otherwise, amounts below are RMB millions.
Life insurance was the dominant business: it contributed 86.2% of 2019 revenue. The company reported 670,104 sales agents at year-end, of whom 394,327 had sold at least one policy during 2019. Its 2019 annual report was filed April 29, 2020.
Key financial metrics
| Metric | FY2018 | FY2019 | Change / note |
|---|---|---|---|
| Net revenue | 3,471.3 | 3,706.0 (US$532.3m) | +6.8% |
| Operating income | 425.7 | 469.4 | +10.2%; operating margin about 12.7% vs. 12.3% |
| Income before tax and affiliate results | 667.2 | 560.9 | −15.9% |
| Net income | 617.1 | 192.6 | −68.8% |
| Net income attributable to shareholders | 609.9 | 188.9 (US$27.1m) | −69.0%; net margin about 5.1% vs. 17.6% |
| Basic / diluted net income per ADS | US$ equivalent not presented | RMB3.46 / RMB3.46 | FY2018 was RMB9.84 / RMB9.83 |
| Net cash from operating activities | 523.8 | 178.3 | −65.9% |
| Cash and cash equivalents at year-end | 772.8 | 169.7 | −78.1% |
| Short-term investments at year-end | 1,554.1 | 1,612.4 | +3.7% |
| Total assets / total liabilities | 3,866.6 / 1,119.9 | 3,440.8 / 1,396.4 | Assets fell; liabilities rose |
| Current assets / current liabilities | 3,061.1 / 905.6 | 2,681.8 / 948.0 | Current ratio about 2.83 vs. 3.38 |
| Bank borrowings | None | None | No short- or long-term bank borrowings reported |
Revenue mix shifted further toward life insurance: life revenue increased 11.2% to RMB3,193.6m; P&C revenue fell 48.1% to RMB141.8m; claims-adjusting revenue grew 13.2% to RMB370.6m. Agency revenue overall increased 6.1% to RMB3,335.4m.
Operating costs and expenses rose 6.3% to RMB3,236.6m, or 87.3% of revenue versus 87.8% in 2018. The filing attributes improved operating-cost leverage mainly to growth in higher-margin renewal life business. It does not provide a single consolidated gross-margin measure.
Investing cash flow was RMB12.0m, versus RMB1,567.6m generated in 2018; financing cash outflow was RMB792.1m, mainly share repurchases of RMB484.0m and dividends of RMB435.1m, partly offset by RMB111.3m in employee and agent subscriptions. Cash, cash equivalents, and restricted cash together were RMB265.6m at year-end. Short-term investments were RMB1,612.4m, so liquidity included substantial invested funds, not just cash.
Material changes versus the prior comparable period
- Revenue growth was led by life insurance, including 45.4% growth in renewal commissions to RMB802.8m and 3.1% growth in first-year commissions to RMB2,390.8m.
- P&C revenue contracted substantially, partly because an insurer stopped underwriting a popular product sold through Baowang. Fanhua also stopped charging CNpad Auto technology service fees in Q4 2019.
- Operating income increased modestly, but net income fell sharply. Investment income declined 59.5% to RMB79.1m, and interest income declined 91.8% to RMB2.8m.
- Share of affiliate results swung from RMB174.5m income to a RMB224.6m loss. This included a RMB322.7m other-than-temporary impairment of Fanhua’s CNFinance investment, partially offset by RMB98.7m of CNFinance equity income.
- Operating cash generation dropped to RMB178.3m, including a RMB180.2m increase in accounts receivable. Huaxia and Sinatay together represented 39.9% of revenue and 44.8% of year-end receivables; the filing says the Sinatay receivable was fully settled in March 2020.
- Total shareholders’ equity fell to RMB1,931.3m from RMB2,633.2m, reflecting, among other items, earnings, dividends, and repurchases. The company repurchased and cancelled 2.51m ADSs for approximately US$70.7m during 2019.
Outlook, risks, contingencies, and unusual items
- Outlook: Management expected life insurance to remain the principal revenue source and anticipated further expansion of its distribution network and online platforms. It said current cash and expected operating cash flow should cover anticipated needs for at least 12 months. No quantified revenue or earnings guidance is provided in the filing.
- COVID-19: The filing says restrictions on face-to-face sales activity had disrupted operations and were expected to adversely affect 2020 results, with first-quarter 2020 operating income expected to fall significantly year over year. Management could not reasonably estimate the pandemic’s full financial effect.
- Partner concentration: Four insurers each exceeded 10% of 2019 revenue: Huaxia 23.8%, Aeon 18.3%, Sinatay 16.1%, and Tian’an 12.1%. Short-term contracts and changes in commissions, products, or partner relationships could affect revenue.
- Regulatory exposure: Proposed internet-insurance rules could require additional licenses, filings, and information-security certification for online platforms and agent applications. Baowang generated 3.3% of 2019 revenue; the company was undertaking rectification and warned operations could be suspended if it failed to comply. The filing also describes agent registration, sales-recording, and product-design requirements that could increase costs or constrain sales.
- Other risks: The filing highlights competition, agent retention, commission-rate changes, China regulatory and legal uncertainty, currency conversion and dividend-repatriation restrictions, and limited PCAOB access to audit inspections in China.
- 521 Plan: The plan involved 280m ordinary shares, participant performance and service conditions, and company-funded loans bearing 8% interest. The share collateral may be insufficient if the stock price falls; loan repayment and participant retention are risks. A 2019 amendment changed settlement from cash to net shares.
- Legal and controls: A U.S. shareholder class action was dismissed and the case closed in March 2020. The company reported RMB750,000 in aggregate regulatory fines in 2019, described as immaterial. Management and the auditor concluded internal control over financial reporting was effective at year-end 2019; a material weakness identified in 2018 was reported as remediated during 2019.
- Contingencies and commitments: The company reported RMB70.4m of uncertain tax liabilities, excluded from the contractual-obligations table because settlement timing could not be estimated. Undiscounted operating lease commitments were RMB204.5m; the company reported no material off-balance-sheet arrangements.
- Dividend: A Q4 2019 dividend of US$0.30 per ADS was declared in March 2020. The filing also announced a 2020 annual dividend plan of US$1.00 per ADS, payable quarterly, based on expected 2020 operating income. Future dividends remain subject to board discretion and PRC distribution restrictions.
Most important facts an investor should verify
- Confirm the issuer and security: this is Fanhua Inc. (FANH), not AIFU Inc.; confirm the requested period is FY2019 rather than Q4 alone.
- Review the CNFinance impairment and its effect on 2019 earnings, along with the investment’s valuation and subsequent performance.
- Assess operating cash flow, the rise in receivables, insurer concentration, and collection status after year-end.
- Check the status and impact of internet-insurance regulatory remediation and any renewed sales-recording requirements.
- Evaluate the 521 Plan’s loan balances, collateral value, performance conditions, and potential implications for employee incentives and shares.
- Monitor COVID-19 effects, 2020 operating performance, and whether the announced dividend plan was maintained.
- Consider PRC restrictions on upstreaming cash, the RMB70.4m uncertain tax liability, and the limits on PCAOB inspection access.